Benzodiazepine analogs
AssigneeMerck & Co., Inc.
InventorsMark G. Bock, Ben E. Evans, Roger M. Freidinger
Life of this patent
Estimating the term…
Abstract
Benzodiazepine analogs of the formula: ##STR1## wherein: R.sup.3 is ##STR2## --NH(CH.sub.2).sub.2 --.sub.3 NHCOR.sup.7, ##STR3## or --X.sup.11 NR.sup.18 SO.sub.2 (CH.sub.2).sub.q R.sup.7 ; R.sup.7 is O,S,HH, or NR.sup.15 with the proviso that X.sup.7 can be NR.sup.15 only when R.sup.1 is not H. are disclosed which are antagonists of gastrin and cholecystokinin (CCK) with enhanced aqueous solubility and have properties useful in the treatment of disorders of gastric secretion, appetite regulation, gastrointestinal motility, pancreatic secretion, and dopaminergic function, as well as in treatment producing potentiation of morphine and other opiate analgesics.
Claims4
A compound of Formula:
- ##STR11## wherein:
- R.sup.1 is H, C.sub.1 -C.sub.6 linear or branched alkyl, loweralkenyl, lower alkynyl, X.sup.12 -COOH, --X.sup.12 COOR.sup.6, --X.sup.11 -cycloloweralkyl, --X.sup.12 NR.sup.4 R.sup.5, --X.sup.12 CONR.sup.4 R.sup.5, --X.sup.12 CN, or --X.sup.11 CX.sub.3.sup.10 ;
- R.sup.2 is H, loweralkyl, substituted or unsubstituted phenyl (wherein the substituents may be 1 or 2 of halo, loweralkyl, loweralkoxy, loweralkythio, carboxyl, carboxyloweralky, nitro, --CF.sub.3, or hydroxy), 2-,3-, or 4-pyridyl;
- R.sup.3 is ##STR12## --NH(CH.sub.2).sub.2 --.sub.3 NHCOR.sup.7, ##STR13## --X.sup.11 NR.sup.18 SO.sub.2 (CH.sub.2).sub.q R.sup.7 ;
- R.sup.4 and R.sup.5 are independently H or R.sup.6 or in combination with the N of the NR.sup.4 R.sup.5 group form an unsubstituted or mono or disubstituted, saturated or unsaturated, 4-7 membered heterocyclic ring, wherein said heterocyclic ring may contain a second heteroatom selected from O and NCH.sub.3 and the substituents(s) is/are independently selected from C.sub.1 -C.sub.4 alkyl;
- R.sup.6 is loweralkyl, cycloloweralkyl, substituted or unsubstituted phenyl, or substituted or unsubstituted phenylloweralkyl wherein the phenyl or phenylloweralkyl substituents may be 1 or 2 of halo, loweralkyl, loweralkoxy, nitro, or CF.sub.3 ;
- R.sup.7 is ##STR14## R.sup.8 is H, loweralkyl, cycloloweralkyl, --X.sup.13 CONH.sub.2, --X.sup.13 COOR.sup.6, --X.sup.13 COOH, --X.sup.13 -cycloloweralkyl, or --X.sup.13 NR.sup.4 R.sup.5,
- R.sup.15 is H, or loweralkyl,
- R.sup.18 is H or loweralkyl;
- n is 1-6,
- q is 0-4;
- r is 1 or 2;
- X.sup.1 is H,--NO.sub.2,CF.sub.3, CN, OH, loweralkyl, halo, loweralkylthio, loweralkoxy, --X.sup.11 COOR.sup.6, X.sup.11 COOH, or --X.sup.11 NR.sup.4 R.sup.5,
- X.sup.2 is H or X.sup.3, with the proviso that when X.sup.2 is H, then X.sup.4 is NX.sup.5 COOH or NX.sup.5 COOR.sup.6 wherein X.sup.5 is a linear alkyl chain of 2 to 6 carbon atoms, any carbon atom of which may be additionally substituted with a linear or branched alkyl group of 1 to 3 carbon atoms;
- X.sup.3 is O(CH.sub.2).sub.n COOR.sup.6, O(CH.sub.2).sub.n COOH, (CH.sub.2).sub.n COOR.sup.6, (CH.sub.2).sub.n COOH, COOR.sup.6, or X.sup.12 OR.sup.6 ;
- X.sup.4 is S,O, CH.sub.2, or NR.sup.8 ;
- X.sup.7 is O,S, HH, or NR.sup.15 with the proviso that X.sup.7 can be NR.sup.15 only when R.sup.1 is not H;
- X.sup.8 is H, loweralkyl;
- X.sup.9 and X.sub.a.sup.9 are independently NR.sup.18 or O;
- X.sup.10 is F, Cl, or Br;
- X.sup.11 is absent or C.sub.1-4 linear or branched alkyl alkylidene;
- X.sup.12 is C.sub.1-4 linear or branched alkylidene,
- X.sup.13 is linear or branched alkylidene.
Dependencies are inferred from the claim text.